iGMDRD58


Canonical SMILES: CC(=O)C1(CCC2C1(CCC3C2C=C(C4=CC(=O)C5CC5C34C)Cl)C)OC(=O)C

InChI: InChI=1S/C24H29ClO4/c1-12(26)24(29-13(2)27)8-6-16-14-10-20(25)19-11-21(28)15-9-18(15)23(19,4)17(14)5-7-22(16,24)3/h10-11,14-18H,5-9H2,1-4H3/t14-,15+,16-,17-,18-,22-,23-,24-/m0/s1

InChI Key: UWFYSQMTEOIJJG-FDTZYFLXSA-N

Loading, please wait...
Standard Name
CHEMBL
Pubchem CID
KEGG Drug ID
DRUGBANK ID
Drug Status
Drug targets (TTD)
Drug Type
Standard NameCyproterone Acetate
Pubchem CID9880
KEGG Drug IDD07766
DRUGBANK IDDB04839
Drug StatusAlone
Drug targets (TTD)DAP000906
Drug TypeSmall Molecule



Drug Pathways:

Oocyte meiosis

Drug-model tissue-cancer distribution: Bubble Plot

PROSTATtissue: PROSTAT cancer: PROSTATE model num: 0PROSTATEtissue: PROSTATE cancer: Prostate Cancer model num: 1

Drug-gene pathway enrichments

1reactome: Metabolism of proteins1reactome: COPII-mediated vesicle transport1reactome: Membrane Trafficking1reactome: ER to Golgi Anterograde Transport1reactome: Asparagine N-linked glycosylation1reactome: Vesicle-mediated transport1reactome: Transport to the Golgi and subsequent modification1reactome: Post-translational protein modification1reactome: Cargo concentration in the ER1kegg: Colorectal cancer - Homo sapiens (human)

Drug-gene GO enrichments

2BP: positive regulation of cell proliferation2BP: epidermal growth factor receptor signaling pathway2CC: extracellular space1BP: mammary gland alveolus development1BP: epithelial cell proliferation involved in mammary gland duct elongation1BP: mammary gland branching involved in thelarche1BP: dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis1BP: response to glucocorticoid1BP: response to cAMP1CC: Golgi membrane

Drug-Gene: Aster Plot


Loading, please wait...
Gene ID
Gene Name
Model Num.
374 AREG 1
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Models in Cyproterone Acetate

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​